Cipla Ltd is set to invest ZAR 900 million in its wholly-owned subsidiary, Cipla Medpro South Africa Proprietary Ltd. The ...

Mumbai: Cipla has announced that the Company will invest approx. ZAR 900 million in equity share capital of Cipla Medpro ...

Asit C Mehta recommended accumulate rating on Cipla with a target price of Rs 1808 in its research report dated January 17 ...

the consumer healthcare subsidiary of Cipla Ltd purchased the nutritional supplement brand Endura Mass from Medinnbelle Herbalcare. Products and services Cipla is among India’s biggest ...

The shares of the third largest pharmaceutical firm Cipla rose 2.44 per cent at Rs 1,454.20 a piece on the BSE intraday after ...

CMSA, is a wholly owned subsidiary of Cipla, and is the holding company for the group operations in South Africa. The group is involved in the manufacturing, marketing, and supply of pharmaceutical ...

The company reported a 48% year-on-year (y-o-y) jump in its consolidated net profit to ₹1,571 crore in October-December, ...

Cipla's US sales are expected to be adversely impacted by price erosion and supply disruptions for tumor drug Lanreotide, ...

Motilal Oswal retains Neutral on Cipla; see limited upside due to delayed niche product approvals. Learn more about the ...

Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the ...

Shares of Cipla Limited climbed 1.91 per cent and traded at Rs 1478.60 apiece, at around 11:40 pm. The stock opened in green at Rs 1455 vs the previous closure of Rs 1450.85. More than 10.44 lakh ...

This achievement has been recognised by the Asia Book of Records for engaging the largest number of doctors in a COPD awareness campaign during COPD Awareness Month.